Effects of 12-Week Methylphenidate Treatment on Neurometabolism in Adult Patients with ADHD: The First Double-Blind Placebo-Controlled MR Spectroscopy Study

Attention deficit hyperactivity disorder (ADHD) is a frequent neurodevelopmental disorder that often persists into adulthood. Methylphenidate (MPH) is the first-line treatment for ADHD; however, despite its wide usage, little is known about its neurometabolic effects. Until now, no randomized and bl...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Simon Maier, Ludger Tebartz van Elst, Alexandra Philipsen, Thomas Lange, Bernd Feige, Volkmar Glauche, Kathrin Nickel, Swantje Matthies, Barbara Alm, Esther Sobanski, Katharina Domschke, Evgeniy Perlov, Dominique Endres
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI AG 2020-08-01
Colecção:Journal of Clinical Medicine
Assuntos:
ADHD
MR spectroscopy
MRS
methylphenidate
glutamate
Acesso em linha:https://www.mdpi.com/2077-0383/9/8/2601
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados